n-methyl-3,4-methylenedioxyamphetamine has been researched along with n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, AJ; Jacob, P; Nichols, DE; Oberlender, RA; Shulgin, AT | 1 |
| Callaway, CW; Geyer, MA | 1 |
| Nichols, DE; Oberlender, R | 1 |
| Johnson, MP; Nichols, DE | 1 |
| Dimpfel, W; Nichols, DE; Spüler, M | 1 |
| Nichols, DE; Steele, TD; Yim, GK | 1 |
| Marona-Lewicka, D; Nichols, DE | 1 |
| Kronstrand, R | 1 |
| Sadeghipour, F; Veuthey, JL | 1 |
| Dulawa, SC; Geyer, MA; Hen, R; Scearce-Levie, KA | 1 |
| Kovar, KA; Mayerhofer, A; Meyer, A; Schmidt, WJ | 1 |
| Kovar, KA; Lebsanft, HB; Mayerhofer, A; Schmidt, WJ | 1 |
| Concheiro, M; Cruz, A; de Castro, A; López-Rivadulla, M; Quintela, O | 1 |
| Corkery, J; Deluca, P; Ghodse, AH; Oyefeso, A; Schifano, F | 1 |
| Ishii, H; Nakagawa, Y; Ogata, A; Suzuki, T; Tayama, S | 1 |
| Maurer, HH; Meyer, MR; Peters, FT | 1 |
16 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and n-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine
| Article | Year |
|---|---|
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.
Topics: Adult; Animals; Butylamines; Dioxoles; Discrimination Learning; Female; Generalization, Stimulus; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychotropic Drugs; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Fluoxetine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1992 |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hallucinogens; Indans; Learning; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Biogenic Monoamines; Brain Chemistry; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Norepinephrine; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1989 |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroencephalography; Evoked Potentials; Hallucinogens; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Telemetry | 1989 |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Biological Transport; Corpus Striatum; Depression, Chemical; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dopamine; Hippocampus; Hypothalamus; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes | 1987 |
Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Behavior, Animal; Discrimination Learning; Dose-Response Relationship, Drug; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Stereoisomerism | 1994 |
Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Calibration; Gas Chromatography-Mass Spectrometry; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reference Standards; Serotonin; Substance-Related Disorders; Sweden | 1996 |
Sensitive and selective determination of methylenedioxylated amphetamines by high-performance liquid chromatography with fluorimetric detection.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Chromatography, High Pressure Liquid; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Substance Abuse Detection; Tablets | 1997 |
Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Mice; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Oxadiazoles; Piperazines; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reflex, Startle; Serotonin; Serotonin Agents; Serotonin Antagonists | 2000 |
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Animals; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2002 |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Agents; Animals; Apomorphine; Behavior, Animal; Citalopram; Dopamine; Fenclonine; Functional Laterality; Hallucinogens; Male; Medial Forebrain Bundle; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotation; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2003 |
Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection.
Topics: 3,4-Methylenedioxyamphetamine; Chromatography, High Pressure Liquid; Forensic Medicine; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Saliva; Spectrometry, Fluorescence; Substance Abuse Detection | 2005 |
Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine-Related Disorders; Cause of Death; Crime; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug and Narcotic Control; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Statistics as Topic; United Kingdom | 2006 |
Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Cell Death; DNA Damage; Hallucinogens; Hepatocytes; Male; Methamphetamine; Mitochondria, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Phosphorylation; Rats; Rats, Inbred F344; Time Factors | 2009 |
Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
Topics: 3,4-Methylenedioxyamphetamine; Antibodies, Monoclonal; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; In Vitro Techniques; Kinetics; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2009 |